Study of CA-18C3 in Subjects With Advanced Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Hematologic Malignancies
Related studies linked through entity extraction aliases.
Study of Red Blood Cell Transfusion Triggers in Patients Undergoing Hematopoietic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE3
Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation
- Status
- UNKNOWN
- Phase
- PHASE3
Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Dose Escalation of IPI-493 in Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Cytokine Induced Killer (CIK) Cells In Leukemia Patients
- Status
- COMPLETED
- Phase
- PHASE2
Total Lymphoid Irradiation and Anti-Thymocyte Globulin in the Allogeneic Hematopoietic Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
Anidulafungin in Patients With Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide
- Status
- COMPLETED
- Phase
- PHASE2
Dose-ranging Study of a Single Administration of T-cell Add-back Depleted of Host Alloreactive Cells in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study Of PF-04449913 In Select Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.
- Status
- COMPLETED
- Phase
- PHASE1
Repeat Dose Safety Study for Compound to Treat Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Reduced Intensity Stem Cell Transplantation (RIST) for Patients With Hematological Malignancies Conditioned With Fludarabine and Busulfan
- Status
- COMPLETED
- Phase
- PHASE2
Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Infusional C-myb ASODN in Advanced Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Conditioning Regimen Before Infusion of Allogeneic Hematopoietic Stem Cells
- Status
- COMPLETED
- Phase
- N/A
Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)
- Status
- COMPLETED
- Phase
- PHASE3
Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies
- Status
- COMPLETED
- Phase
- NA